Delivery Order SPE2DB20D1100-SPE2DB24FZ10E
- Not listed
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563402360 - Aripiprazole 1 mg/ml solution 150ml. The contract has a ceiling value of $1,253.32 and a completion date of January 23, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for 4564161107 - ARIPIPRAZOLE 1 MG/ML SOLUTION 150ML, with a ceiling value of $3,701.55 and a performance period through April 4, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,066.76 Firm Fixed Price Delivery Order covers the supply of ARIPIPRAZOLE 2 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Aripiprazole 1 mg/ml Solution in a 150 ml quantity, with a ceiling value of $1,388.25 and a firm fixed price structure. This competitive award, which requires completion by December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $11,494.62 fixed-price contract is for the supply of Aripiprazole 1 mg/ml solution, a generic prescription medication. The award has an ultimate completion date of July 31, 2024. Amerisourcebergen, through its Corporate Office division, has been a significant provider of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Aripiprazole 5 mg tablets. The contract has a potential value of $1,745.77 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,553.40 firm fixed-price delivery order contract is for the provision of 4555405743 ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. The award has an ultimate completion date of November 15, 2021 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,860.07 firm-fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a medication used for mental health treatment. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.17 firm fixed price delivery order is for the supply of ABILIFY MAINTENA ER 300 MG VLS, a mental health treatment medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.17 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ10EDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,951.00 firm fixed-price delivery order is for the supply of Aripiprazole 1 mg/ml solution (150 ml) to support military healthcare programs. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. The company also maintains a separate $750,000.00 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contract vehicles enable efficient government procurement of essential healthcare items for military personnel, veterans, and other federal beneficiaries. The current award was made through full and open competition with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 12/4/23 |